Heidaran MA - Search Results

1

Inductive activity of recombinant human growth and differentiation factor-5.

Spiro RC, Liu L, Heidaran MA, Thompson AY, Ng CK, Pohl J, Poser JW. Spiro RC, et al. Among authors: heidaran ma. Biochem Soc Trans. 2000;28(4):362-8. Biochem Soc Trans. 2000. PMID: 10961920

2

An osteoconductive collagen/hyaluronate matrix for bone regeneration.

Liu LS, Thompson AY, Heidaran MA, Poser JW, Spiro RC. Liu LS, et al. Among authors: heidaran ma. Biomaterials. 1999 Jun;20(12):1097-108. doi: 10.1016/s0142-9612(99)00006-x. Biomaterials. 1999. PMID: 10382825

3

Convergence of molecular signaling and tissue engineering.

Heidaran MA. Heidaran MA. Ann N Y Acad Sci. 2002 Jun;961:156-7. doi: 10.1111/j.1749-6632.2002.tb03070.x. Ann N Y Acad Sci. 2002. PMID: 12081886 Review. No abstract available.

4

Molecular signaling in bioengineered tissue microenvironments.

Bottaro DP, Liebmann-Vinson A, Heidaran MA. Bottaro DP, et al. Among authors: heidaran ma. Ann N Y Acad Sci. 2002 Jun;961:143-53. doi: 10.1111/j.1749-6632.2002.tb03068.x. Ann N Y Acad Sci. 2002. PMID: 12081884 Review.

5

Carboxyl-terminal domain of p27Kip1 activates CDC2.

Uren A, Jakus J, Font de Mora J, Yeudall A, Santos E, Gutkind S, Heidaran MA. Uren A, et al. Among authors: heidaran ma. J Biol Chem. 1997 Aug 29;272(35):21669-72. doi: 10.1074/jbc.272.35.21669. J Biol Chem. 1997. PMID: 9268291 Free article.

6

PLC-gamma activation is required for PDGF-betaR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells.

Alimandi M, Heidaran MA, Gutkind JS, Zhang J, Ellmore N, Valius M, Kazlauskas A, Pierce JH, Li W. Alimandi M, et al. Among authors: heidaran ma. Oncogene. 1997 Jul 31;15(5):585-93. doi: 10.1038/sj.onc.1201221. Oncogene. 1997. PMID: 9247312

7

Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF.

Lopez-Ilasaca M, Li W, Uren A, Yu JC, Kazlauskas A, Gutkind JS, Heidaran MA. Lopez-Ilasaca M, et al. Among authors: heidaran ma. Biochem Biophys Res Commun. 1997 Mar 17;232(2):273-7. doi: 10.1006/bbrc.1997.6289. Biochem Biophys Res Commun. 1997. PMID: 9125162

8

Oncogenic activation of the alphaPDGFR defines a domain that negatively regulates receptor dimerization.

Uren A, Yu JC, Karcaaltincaba M, Pierce JH, Heidaran MA. Uren A, et al. Among authors: heidaran ma. Oncogene. 1997 Jan 16;14(2):157-62. doi: 10.1038/sj.onc.1200810. Oncogene. 1997. PMID: 9010217

9

Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.

Li W, Michieli P, Alimandi M, Lorenzi MV, Wu Y, Wang LH, Heidaran MA, Pierce JH. Li W, et al. Among authors: heidaran ma. Oncogene. 1996 Aug 15;13(4):731-7. Oncogene. 1996. PMID: 8761294

10

Identification of a domain within the carboxyl-terminal region of the beta platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF.

Uren A, Yu JC, Li W, Chung IY, Mahadevan D, Pierce JH, Heidaran MA. Uren A, et al. Among authors: heidaran ma. J Biol Chem. 1996 May 10;271(19):11051-4. doi: 10.1074/jbc.271.19.11051. J Biol Chem. 1996. PMID: 8626645 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters